T-knife

Berlin, Germany

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

Aug 2021

Series B

Top Investors

RA Capital ManagementAndera PartnersEQT Life SciencesFidelityVersant Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are T-knife's investors?

T-knife's investors include RA Capital Management, Andera Partners, EQT Life Sciences, Fidelity, Versant Ventures.

Where is T-knife headquartered?

T-knife is headquartered in Berlin, Germany.

What does T-knife do?

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

What stage is T-knife at?

T-knife is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 2, 2021.

MLA

"T-knife — Funding & Investors." VCBacked, August 2, 2021, https://www.vcbacked.co/company/t-knife. Accessed July 1, 2026.

APA

VCBacked. (2021). T-knife — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/t-knife

Wikipedia (cite web)

{{cite web |title=T-knife — Funding & Investors |url=https://www.vcbacked.co/company/t-knife |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 2, 2021.